FIRST half revenue for digital medication management company MedAdvisor totalled $3.15m, double the figure for the previous corresponding period.
According to a quarterly update issued on Fri, other key milestones included the $9.5 investment by EBOS Group (PD 25 Oct 2017), while more than half of all Australian pharmacies are now on board and approximately 960,000 patients have been added to the MedAdvisor platform.
The company said that its agreement with Terry White Chemmart has cemented its position as the preferred provider to its pharmacy network, many members of which were already existing MedAdvisor customers.
CEO Robert Read said, "This quarter was a momentous quarter for MedAdvisor with the rolling out of our PlusOne platform to MedAdvisor sites and receiving such huge validation from leading healthcare group EBOS."
He added the company will extend its focus to hospital markets to improve transition of care.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jan 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jan 18